CA3092156A1 - Species specific antigen sequences for tick-borne relapsing fever (tbrf) and methods of use - Google Patents

Species specific antigen sequences for tick-borne relapsing fever (tbrf) and methods of use Download PDF

Info

Publication number
CA3092156A1
CA3092156A1 CA3092156A CA3092156A CA3092156A1 CA 3092156 A1 CA3092156 A1 CA 3092156A1 CA 3092156 A CA3092156 A CA 3092156A CA 3092156 A CA3092156 A CA 3092156A CA 3092156 A1 CA3092156 A1 CA 3092156A1
Authority
CA
Canada
Prior art keywords
seq
tbrf
amino acid
sample
acid sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3092156A
Other languages
English (en)
French (fr)
Inventor
Jyotsna S. Shah
Song Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ID FISH Tech Inc
Original Assignee
ID FISH Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ID FISH Tech Inc filed Critical ID FISH Tech Inc
Publication of CA3092156A1 publication Critical patent/CA3092156A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA3092156A 2018-03-09 2019-03-07 Species specific antigen sequences for tick-borne relapsing fever (tbrf) and methods of use Pending CA3092156A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/916,717 2018-03-09
US15/916,717 US10718767B2 (en) 2018-03-09 2018-03-09 Species specific antigen sequences for tick-borne relapsing fever (TBRF) and methods of use
PCT/US2019/021113 WO2019173569A1 (en) 2018-03-09 2019-03-07 Species specific antigen sequences for tick-borne relapsing fever (tbrf) and methods of use

Publications (1)

Publication Number Publication Date
CA3092156A1 true CA3092156A1 (en) 2019-09-12

Family

ID=67843846

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3092156A Pending CA3092156A1 (en) 2018-03-09 2019-03-07 Species specific antigen sequences for tick-borne relapsing fever (tbrf) and methods of use

Country Status (5)

Country Link
US (2) US10718767B2 (https=)
EP (1) EP3762725B1 (https=)
JP (1) JP7366041B2 (https=)
CA (1) CA3092156A1 (https=)
WO (1) WO2019173569A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220229055A1 (en) * 2021-01-15 2022-07-21 Id-Fish Technology, Inc. Species-specific antigen sequences for tick-borne relapsing fever (tbrf) and methods of use
BR112023021860A2 (pt) * 2021-04-23 2023-12-19 Id Fish Tech Inc Composição, método para detectar infecção por uma ou mais espécies de babesia, método para detectar infecção espécie-específica por b. microti ou b. duncani e vetor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE142888T1 (de) * 1990-03-05 1996-10-15 Us Health Antigen-wirkende proteine von borrelia burgdorferi
WO1996022392A2 (en) * 1995-01-19 1996-07-25 Gen-Probe Incorporated Nucleic acid amplification oligonucleotides and probes to lyme disease associated borrelia
US8247181B2 (en) * 2007-09-07 2012-08-21 The Regents Of The University Of California Borrelia diagnostics and screening methods
WO2011163258A2 (en) * 2010-06-21 2011-12-29 Pharmason Labs, Inc. Compositions and methods for diagnosing and monitoring disease and treatment via antigen-specific molecules
HK1244534A1 (zh) 2014-10-07 2018-08-10 The Research Foundation For The State University Of New York 重组疏螺旋体蛋白及其使用方法
US20190093149A1 (en) * 2017-09-27 2019-03-28 The United States Of America, As Represented By The Secretary Of Agriculture Assays for detecting multiple tick-borne pathogens

Also Published As

Publication number Publication date
EP3762725A4 (en) 2022-03-09
US20190277847A1 (en) 2019-09-12
EP3762725B1 (en) 2024-10-23
JP7366041B2 (ja) 2023-10-20
US20200348301A1 (en) 2020-11-05
WO2019173569A1 (en) 2019-09-12
US11353457B2 (en) 2022-06-07
US10718767B2 (en) 2020-07-21
EP3762725A1 (en) 2021-01-13
JP2021516340A (ja) 2021-07-01

Similar Documents

Publication Publication Date Title
Dechamma et al. Identification of T-helper and linear B epitope in the hypervariable region of nucleocapsid protein of PPRV and its use in the development of specific antibodies to detect viral antigen
Noordhoek et al. A new attempt to distinguish serologically the subspecies of Treponema pallidum causing syphilis and yaws
Tokarz et al. Identification of immunoreactive linear epitopes of Borrelia miyamotoi
US11353457B2 (en) Species specific antigen sequences for tick-borne relapsing fever (TBRF) and methods of use
US12239696B2 (en) Chimeric vaccine antigens for anaplasmosis
WO2017100598A1 (en) Babesia biomarkers for diagnostic and screening in vitro diagnostic test
US20130251749A1 (en) Methods and compositions for chlamydial antigens as reagents/strategies for diagnosis and treatment of chlamydial infection and disease
CN101970463A (zh) 用于检测恰菲埃里希氏体(vlpt)的方法和组合物
US12298312B2 (en) Detection of Lyme disease
CN106248934A (zh) 结核分枝杆菌抗原蛋白Rv0446c及其T细胞表位肽的应用
Cauchard et al. Assessment of the safety and immunogenicity of Rhodococcus equi-secreted proteins combined with either a liquid nanoparticle (IMS 3012) or a polymeric (PET GEL A) water-based adjuvant in adult horses and foals—identification of promising new candidate antigens
Pollock et al. Peptide mapping of bovine T‐cell epitopes for the 38 kDa tuberculosis antigen
McDonagh et al. Development of an antigen-based rapid diagnostic test for the identification of blowfly (Calliphoridae) species of forensic significance
Andre-Fontaine et al. Undiagnosed leptospirosis cases in naïve and vaccinated dogs: Properties of a serological test based on a synthetic peptide derived from Hap1/LipL32 (residues 154–178)
US11899015B1 (en) Chimeric recombinant proteins and recombinant protein panels for the diagnosis of Lyme disease in animals and humans
US20130115639A1 (en) Method for detecting a salmonella infection
da Silva Mol et al. Laboratorial diagnosis of animal brucellosis
US20240192209A1 (en) Diagnosis of bartonella using recombinant proteins
WO2012142022A1 (en) Assays, compositions, systems, kits, and devices for diagnosing typhoid fever
WO2024091264A1 (en) Chimeric recombinant proteins and recombinant protein panels for the diagnosis of lyme disease in animals and humans
MONTES DE OCA JIMENEZ et al. The Use of Peptides in Veterinary Serodiagnosis of Infectious Diseases: A Review
JP2024505438A (ja) ダニ媒介性回帰熱（ｔｂｒｆ）の種特異的抗原配列及び利用法
de Toulouse-Lautrec et al. syphilis. Composers Franz Schubert (1797–1828) Robert Schumann (1810–1856) Gangster Al Capone (1899–1947) Painters Paul Gauguin (1848–1903)
Minda Asfaw Geresu et al. A review on diagnostic methods of brucellosis.
EP3695228A1 (en) Chlamydia suis diagnosis

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20231218

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD

Year of fee payment: 6

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250228

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250303

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250303

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250606

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D138 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: INTERVIEW PERFORMED

Effective date: 20250805

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D136 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: INTERVIEW REQUEST AUTHORIZED

Effective date: 20250805

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D135 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: INTERVIEW REQUEST RECEIVED

Effective date: 20250805

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20250923

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20251125

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20251125

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20251125